Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 1 49-1, 2004, Pages

  Nielsen, Michael F ^a,b   Caumo, Andrea ^c   Chandramouli, Visvanathan ^e   Schumann, William C ^e   Cobelli, Claudio ^d   Landau, Bernard R ^e   Vilstrup, Hendrik ^b   Rizza, Robert A ^f   Schmitz, Ole ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MAYO CLINIC   (United States)

Author keywords

Insulin action

Indexed keywords

FATTY ACID; GLUCOSE; HYDROCORTISONE; INSULIN; SODIUM CHLORIDE; SOMATOSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; HYPERCORTISOLISM; INFUSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL;

EID: 0346787539     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00566.2002     Document Type: Article

References (47)

1. Alzaid AA, Dinneen SF, Turk DJ, Caumo A, Cobelli C, and Rizza RA. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest 94: 2341-2348, 1994.
2. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, and Rødder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39: 578-582, 1993.
3. Andrews RC and Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Colch) 96: 513-523, 1999.
4. Baron AD, Wallace P, and Brechtel G. In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by cortisol. Diabetes 36: 1230-1237, 1987.
5. Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, and Rizza RA. Impaired basal glucose effectiveness in NIDDM. Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes 46: 421-432, 1997.
6. Beck-Nielsen H, De Pirro R, and Pedersen O. Prednisone increases in the number of insulin receptors on monocytes from normal subjects. J Clin Endocrinol Metab 50: 1-4, 1980.
7. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, and Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19: 1018-1030, 1996.
8. Bradley DC, Steil GM, and Bergman RN. Quantitation of measurement error with Optimal Segments: basis for adaptive time course smoothing. Am J Physiol Endocrinol Metab 264: E902-E911, 1993.
9. Chernow B, Alexander HR, Smallridge RC, Thomsen WR, Cook D, Fink MP, Lake CR, and Fletcher JR. Hormonal responses to graded surgical stress. Arch Intern Med 147: 1273-1278, 1987.
10. Dinneen S, Alzaid A, Miles J, and Rizza R. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J Clin Invest 91: 2283-2290, 1993.
11. Dinneen S, Alzaid A, Miles J, and Rizza RA. Effects of the normal nocturnal rise in cortisol on carbohydrate and fat metabolism in IDDM. Am J Physiol Endocrinol Metab 268: E595-E603, 1995.
12. Dinneen S, Gerich J, and Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327: 707-713, 1992.
13. Dinneen SF. The effects of glucocorticoid hormones on substrate metabolism. In: Clinical Research in Diabetes and Obesity, Part I: Methods, Assessment and Metabolic Regulation. Totowa, NJ: Humana, 1997, p. 243-257.
14. Fantus IG, Ryan J, Hizuka N, and Gorden P. The effect of glucocorticoids on the insulin receptor: an in vivo and in vitro study. J Clin Endocrinol Metab 52: 953-960, 1981.
15. Finegood DT and Tzur D. Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am J Physiol Endocrinol Metab 271: E485-E495, 1996.
16. Fleig WE, Noether-Fleig G, Roeben H, and Ditschuneit H. Hormonal regulation of key gluconeogenic enzymes and glucose release in cultured hepatocytes: effects of dexamethasone and gastrointestinal hormones on glucagon action. Arch Biochem Biophys 229: 368-378, 1984.
17. 12 myotubes and rat skeletal muscle. Diabetes 44: 646-651, 1995.
18. Gill A, Johnston DG, Ørskov H, Batstone GF, and Alberti KGMM. Metabolic interactions of glucagon and cortisol in man-studies with somatostatin. Metabolism 31: 305-311, 1982.
19. Goldstein RE, Reed GW, Wasserman DH, Williams PE, Lacy DB, Buckspan R, Abumrad NN, and Cherrington AD. The effect of acute elevations in plasma cortisol levels on alanine metabolism in the conscious dog. Metabolism 41: 1295-1303, 1992.
20. Goldstein RE, Wasserman DH, McGuinness OP, Lacy DB, Cherrington AD, and Abumrad NN. Effects of chronic elevation in plasma cortisol on hepatic carbohydrate metabolism. Am J Physiol Endocrinol Metab 264: E119-E127, 1993.
21. Heaney AP, Harper R, Ennis C, Rooney DP, Sheridan B, Atkinson AB, and Bell PM. Insulin action and hepatic glucose cycling in Cushing's syndrome. Clin Endocrinol 46: 735-:743, 1997.
22. Kahn CR, Goldfine ID, Neville DM, and De Meyts P. Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology 103: 1054-;1066, 1978.
23. Karnieli E, Cohen P, Barzilai N, Ish-Shalom Z, Armoni M, Rafaelov R, and Barzilai D. Insulin resistance in Cushing's syndrome. Horm Metab Res 17: 518-521, 1985.
24. Landau BR. Methods for measuring glycogen cycling. Am J Physiol Endocrinol Metab 281: E413-E419, 2001.
25. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, and Kalhan SC. Contribution of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98: 378-385, 1996.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
27. Matthews JN, Altman DG, Campbell MJ, and Royston P. Analysis of serial measurements in medical research. Br Med J 300: 230-235, 1990.
28. McMahon M, Gerich J, and Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 4: 17-30, 1988.
29. Murton SA, Tan ST, Prickett TCR, Frampton C, and Donald RA. Hormone responses to stress in patients with major burns. Br J Plast Surg 51: 388-392, 1998.
30. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, and Rizza RA. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes. Evidence for a concentration-dependent defect in uptake. Diabetes 47: 1735-1747, 1998.
31. Nielsen MF, Nyholm B, Caumo A, Chandramouli V, Schumann WC, Cobelli C, Landau BR, Rizza RA, and Schmitz O. Prandial glucose effectiveness and fasting gluconeogenesis are unaltered in insulin resistant first-degree relatives of patients with type 2 diabetes. Diabetes 49: 2135-2141, 2000.
32. 2+ dependent mechanism. Diabetes 44: 1345-1348, 1995.
33. Nosadini R, Del Prato S, Tiengo A, Valerio A, Muggeo M, Opocher G, Mantero F, Duner E, Marescotti C, Mollo F, and Belloni F. Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab 57: 529-536, 1983.
34. Offner PJ, Moore EE, and Ciesla D. The adrenal response after severe trauma. Am J Surg 184: 649-653, 2002.
35. Olefsky J. Effect of dexamethasone on insulin binding, glucose transport and glucose oxidation of isolated rat adipocytes. J Clin Invest 56: 1499-1508, 1975.
36. Page R, Boolell M, Kalfas A, Sawyer S, Pestell R, Gleen W, and Alford F. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis. Clin Endocrinol 35: 509-517, 1991.
37. Perseghin G, Caumo A, Caloni M, Testolin G, and Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 86: 4776-4781, 2001.
38. Petersen KF, Laurent D, Rothman DL, Cline GW, and Shulman GI. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101: 1203-1209, 1998.
39. Quon MJ, Cochran C, Taylor SI, and Eastman RC. Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes 43: 890-896, 1994.
40. Rizza RA, Mandarino L, and Gerich J. Cortisol induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action. J Clin Endocrinol Metab 54: 131-138, 1982.
41. Rooney DP, Neely RDG, Cullen C, Ennis CN, Sheridan B, Atkinson AB, Trimble ER, and Bell PM. The effect of cortisol on glucose/glucose-6-phosphate cycle activity and insulin action. J Clin Endocrinol Metab 77: 1180-1183, 1993.
42. Samra JS, Clark ML, Humphreys SM, MacDonald I, Bannister PA, and Frayn KN. Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J Clin Endocrinol Metab 83: 626-631, 1998.
43. Sasaki K, Cripe TP, Koch SR, Andreone TL, Peterson DD, Beale EG, and Granner DK. Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 259: 15242-15251, 1984.
44. Steele R, Wall JS, De Bodo RC, Altszuler N, Kiang SP, and Bjerknes C. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
45. Turner RC, Holman RR, Matthews D, Hockaday TDR, and Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28: 1086-1096, 1979.
46. Wang P, Ba ZF, Jarrar D, Cioffi WG, Bland KI, and Chaudry IH. Mechanism of adrenal insufficiency following trauma and severe hemorrhage: role of hepatic 11beta-hydroxysteroid dehydrogenase. Arch Surg 134: 394-401, 1999.
47. Zennaro MC. Syndromes of glucocorticoid and mineralocorticoid resistance. Eur J Endocrinol 139: 127-138, 1998.